Raymond J. Kreienkamp

Raymond J. Kreienkamp

Auto-generated profile, based on publicly available information

Raymond J. Kreienkamp

Boston Children's Hospital

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Ageing Research Reviews
Verified
Journal Article
Open access
SGSusana Gonzalo-Hervas
Susana Gonzalo-Hervas
RKRay Kreienkamp
Ray Kreienkamp
Peter AskjaerPeter Askjaer
Peter Askjaer
Products of the LMNA gene, primarily lamin A and C, are key components of the nuclear lamina, a proteinaceous meshwork that underlies the inner nuclear membrane and is essential for proper nuclear architecture. Alterations in lamin A and C that disrupt the integrity of the nuclear lamina affect a whole repertoire of nuclear functions, causing cellular decline. In humans, hundreds of mutations in the LMNA gene have been identified and correlated with over a dozen degenerative disorders, referred to as laminopathies. These diseases include neuropathies, muscular dystrophies, lipodystrophies, and premature aging diseases. This review focuses on one of the most severe laminopathies, Hutchinson-Gilford Progeria Syndrome (HGPS), which is caused by aberrant splicing of the LMNA gene and expression of a mutant product called progerin. Here, we discuss current views about the molecular mechanisms that contribute to the pathophysiology of this devastating disease, as well as the strategies being tested in vitro and in vivo to counteract progerin toxicity. In particular, progerin accumulation elicits nuclear morphological abnormalities, misregulated gene expression, defects in DNA repair, telomere shortening, and genomic instability, all of which limit cellular proliferative capacity. In patients harboring this mutation, a severe premature aging disease develops during childhood. Interestingly, progerin is also produced in senescent cells and cells from old individuals, suggesting that progerin accumulation might be a factor in physiological aging. Deciphering the molecular mechanisms whereby progerin expression leads to HGPS is an emergent area of research, which could bring us closer to understanding the pathology of aging.

1 June 2015 in Current Opinion in Cell Biology
Verified
Journal Article
Closed access
SGSusana Gonzalo-Hervas
Susana Gonzalo-Hervas
RKRay Kreienkamp
Ray Kreienkamp

5 October 2023 in Communications Medicine
Verified
Journal Article
Open access
PDF file
SMShivani Misra
Shivani Misra
RWRobert Wagner
Robert Wagner
BOBige Ozkan
Bige Ozkan
MSMartin Schön
Martin Schön
MSMagdalena Sevilla-Gonzalez
Magdalena Sevilla-Gonzalez
MUMiriam S. Udler
Miriam S. Udler
Background: Heterogeneity in type 2 diabetes presentation and progression suggests that precision medicine interventions could improve clinical outcomes. We undertook a systematic review to determine whether strategies to subclassify type 2 diabetes were associated with high quality evidence, reproducible results and improved outcomes for patients. Methods: We searched PubMed and Embase for publications that used ‘simple subclassification’ approaches using simple categorisation of clinical characteristics, or ‘complex subclassification’ approaches which used machine learning or ‘omics approaches in people with established type 2 diabetes. We excluded other diabetes subtypes and those predicting incident type 2 diabetes. We assessed quality, reproducibility and clinical relevance of extracted full-text articles and qualitatively synthesised a summary of subclassification approaches. Results: Here we show data from 51 studies that demonstrate many simple stratification approaches, but none have been replicated and many are not associated with meaningful clinical outcomes. Complex stratification was reviewed in 62 studies and produced reproducible subtypes of type 2 diabetes that are associated with outcomes. Both approaches require a higher grade of evidence but support the premise that type 2 diabetes can be subclassified into clinically meaningful subtypes. Conclusion: Critical next steps toward clinical implementation are to test whether subtypes exist in more diverse ancestries and whether tailoring interventions to subtypes will improve outcomes.

27 April 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
RKRay Kreienkamp
Ray Kreienkamp
MCMonica Croke
Monica Croke
MNMartin A. Neumann
Martin A. Neumann
GBGonzalo Bedia-Diaz
Gonzalo Bedia-Diaz
SGSimona Graziano
Simona Graziano
SGSusana Gonzalo-Hervas
Susana Gonzalo-Hervas
Vitamin D receptor signaling improves Hutchinson-Gilford progeria syndrome cellular phenotypes

5 May 2025 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
JCJoanne B. Cole
Joanne B. Cole
EDEmma H. Dahlström
Emma H. Dahlström
DFDamian Fermin
Damian Fermin
YGYogesh Gupta
Yogesh Gupta
Claire HillClaire Hill
Claire Hill
JHJoel N. Hirschhorn
Joel N. Hirschhorn
Key Points: Comprehensive genome-wide association study of eGFR in diabetes, accounting for diabetes duration, kidney disease, and known modifiers, identified novel genetic effects. Incorporation of various kidney multi-omics data provides supporting evidence for the role of novel genome-wide association study loci in diabetic kidney disease. Background: Diabetic kidney disease (DKD) is a serious diabetes complication caused by both environmental and genetic risk factors. Previous genome-wide association studies (GWAS) have identified several loci associated with kidney function and kidney disease in the general population and, to a lesser extent, in diabetes. Methods: To uncover the genetic factors driving diabetes-induced kidney function, we conducted a series of GWAS meta-analyses of eGFR in 17,267 individuals with type 1 diabetes and 35,264 with type 2 diabetes (52,531 total), using multiple well-characterized cohorts of type 1 diabetes DKD and data from the UK Biobank and SUrrogate markers for Micro- and Macrovascular hard end points for Innovative diabetes Tools (SUMMIT) consortium. We further accounted for DKD case/control status, diabetes duration and subtype, body mass index, glycated hemoglobin levels, and the relationship between eGFR and albuminuria. Results: GWAS identified 13 loci associated with eGFR ( P < 5×10 −8 ), with five loci (candidate genes: HIPK3 , TRIM5 , RORA , ERBB4 , and BCL6 / LPP ) not associated with or were in opposite directions as compared with eGFR in the general population. Four candidate genes ( HIPK3 , BCL6, LPP , and RORA ) demonstrated evidence of differential expression in kidney compartments and cells among subgroups with DKD or diabetes versus controls. Lead single-nucleotide polymorphisms rs8027829 ( RORA ) and rs76300256 ( BCL6/LPP ) were methylation quantitative trait loci in whole blood and kidney tissue, respectively, and rs76300256 and its related CpGs all cluster in a kidney enhancer. Conclusions: Our integrated approach identified candidate genes with diabetes-specific effects on kidney function.

1 September 2013 in Nucleus
Verified
Journal Article
Open access
PDF file
ADArindam Das
Arindam Das
DGDavid A Grotsky
David A Grotsky
MNMartin A Neumann
Martin A Neumann
RKRay Kreienkamp
Ray Kreienkamp
IGIgnacio Gonzalez-Suarez
Ignacio Gonzalez-Suarez
SGSusana Gonzalo-Hervas
Susana Gonzalo-Hervas
Over 300 mutations in the LMNA gene, encoding A-type lamins, are associated with 15 human degenerative disorders and premature aging syndromes. Although genomic instability seems to contribute to the pathophysiology of some laminopathies, there is limited information about what mutations cause genomic instability and by which molecular mechanisms. Mouse embryonic fibroblasts depleted of A-type lamins or expressing mutants lacking exons 8–11 (LmnaΔ8–11/Δ8–11) exhibit alterations in telomere biology and DNA repair caused by cathepsin L-mediated degradation of 53BP1 and reduced expression of BRCA1 and RAD51. Thus, a region encompassing exons 8–11 seems essential for genome integrity. Given that deletion of lamin A exon 9 in the mouse (LmnaΔ9/Δ9) results in a progeria phenotype, we tested if this domain is important for genome integrity. LmnaΔ9/Δ9 MEFs exhibit telomere shortening and heterochromatin alterations but do not activate cathepsin L-mediated degradation of 53BP1 and maintain expression of BRCA1 and RAD51. Accordingly, LmnaΔ9/Δ9 MEFs do not present genomic instability, and expression of mutant lamin A Δexon9 in lamin-depleted cells restores DNA repair factors levels and partially rescues nuclear abnormalities. These data reveal that the domain encoded by exon 9 is important to maintain telomere homeostasis and heterochromatin structure but does not play a role in DNA repair, thus pointing to other exons in the lamin A tail as responsible for the genomic instability phenotype in LmnaΔ8–11/Δ8–11 mice. Our study also suggests that the levels of DNA repair factors 53BP1, BRCA1 and RAD51 could potentially serve as biomarkers to identify laminopathies that present with genomic instability.